# Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

> **NCT03476317** · PHASE2 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 10 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Neomycin
- **DRUG:** Ciprofloxacin
- **DRUG:** Polyethylene Glycol 3350
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT03476317
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-12
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03476317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03476317, "Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03476317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*